Signaling Pathways - potassium channel - p53-MDM2 interaction - Aurora Kinases - DPP-4
清除全部
-
A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3抑制剂 -
B3941 Talabostat mesylate2 CitationTarget: DPP-4Summary: DPP4抑制剂 -
A8807 MK-8745Target: Aurora KinasesSummary: Aurora A的强效选择性抑制剂。 -
A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂 -
A8650 Saxagliptin中文名: 沙格列汀Target: DPP-4Summary: DPP4抑制剂 -
A2005 Nutlin-3bTarget: p53-MDM2 interactionSummary: MDM2/p53抑制剂 -
A4489 TC-A 2317 hydrochlorideTarget: Aurora KinasesSummary: Aurora kinase A抑制剂 -
A3865 Teneligliptin hydrobromide中文名: 氢溴酸替格列汀Target: DPP-4Summary: DDP4抑制剂 -
A3760 Reversine中文名: 逆转素Target: Aurora KinasesSummary: Aurora激酶抑制剂 -
A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂